The mRNA expression levels of Wisp1 , Bmp3b and follistatin in the TA muscles tended to be increased in GIP receptor antagonist‐treated Gipr +/+ mice relative to untreated Gipr +/+ mice, although their differences did not reach statistical significance ( Figure 5 D ).
← all excerpts
Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia.
1
—
—